CYTEK BIOSCIENCES, INC. (CTKB) Gross margin 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) gross margin by fiscal year — reported gross profit divided by reported revenue.
51.8%FY2025 · since FY2020: 55.7% → 51.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 51.8% | -3.6 pp |
| FY2024 | 55.4% | -1.3 pp |
| FY2023 | 56.7% | -4.9 pp |
| FY2022 | 61.6% | -0.3 pp |
| FY2021 | 61.9% | +6.2 pp |
| FY2020 | 55.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice